Mental Health Clinics in Bee Cave, TX Accepting Medicare
6 Mental Health Clinics found. Showing 1 - 6
 Ellie Mental Health Counselor - Professional Medicare: Not Enrolled in Medicare Practice Location: 11719 Bee Caves Rd Ste 200, Bee Cave, TX 78738 Phone: 737-301-8668 |
Cultivate Behavioral Health And Education Behavioral Analyst Medicare: Not Enrolled in Medicare Practice Location: 3944 Rr 620 S Ste 201, Bee Cave, TX 78738 Phone: 512-772-4042 |
Hill Behavioral Wellness, Llc Psychologist - Clinical Medicare: Medicare Enrolled Practice Location: 12600 Hill Country Blvd Ste R-275, Bee Cave, TX 78738 Phone: 512-697-9123 |
Integrative Psychological Services, Pllc Psychologist - Cognitive & Behavioral Medicare: Not Enrolled in Medicare Practice Location: 11701 Bee Caves Rd, Ste. 205, Bee Cave, TX 78738 Phone: 512-261-8273 Fax: 888-746-2837 |
Journey Clinical Psychiatry Tx Pc Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 12600 Hill Country Blvd Ste R-275, Bee Cave, TX 78738 Phone: 917-274-7730 |
Vivid Living Therapy, Pllc Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 12600 Hill Country Blvd Ste R-275, Bee Cave, TX 78738 Phone: 512-781-1172 |
News Archive
Latest round of REACT-1 finds SARS-CoV-2 prevalence has halved since previous round
Researchers in the UK say the latest round of the REal-time Assessment of Community Transmission-1 (REACT-1) study has found that the prevalence of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19) – has fallen by 50%, compared with the previous round conducted in March of this year (2021).
Infinity to present data from Hsp90 chaperone and Hedgehog pathway inhibitor programs at 2010 ASCO
Infinity Pharmaceuticals, Inc., an innovative drug discovery and development company, today announced that data from its Hsp90 chaperone and Hedgehog pathway inhibitor programs will be presented during the 2010 American Society of Clinical Oncology (ASCO) Annual Meeting being held in Chicago, Ill. from June 4 through June 8, 2010.
Blood pressure management may slow cognitive decline in PD
Cognitive dysfunction in Parkinson's disease is linked to neurocirculatory abnormalities such as orthostatic and supine hypertension, suggesting early treatment of such abnormalities may slow cognitive decline, say researchers.
Study of patients on COX-2 inhibitors does not show increased cardiovascular risk
An observational study of 6,250 patients enrolled in the Maryland Medicaid program found that COX-2 inhibitors did not increase the risk for cardiovascular events over nonnaproxen NSAIDs in a high-risk population.
› Verified 4 days ago